Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

NCT05204524 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Chinese Academy of Medical Sciences